Search results for: Economics of Innovation

Due to the Unprecedented Nature of H.R. 3, the CBO Analysis is Unreliable and Can’t Inform Policymaking

15 September 2021

…is Changing The CBO’s estimate of the impact of innovation is forecast from a baseline of innovation as measured by the number of new drugs approved by the FDA in…

Advancing Rare Disease Care: Challenges and Key Issues

28 February 2025

…the past several decades. In this article, which is jointly authored by members of OHE’s Economics of Innovation research team, we want to show you why we still care about…

CBO Doesn’t Capture The Real Impact of H.R. 3 on Innovation 

14 September 2021

…volume of innovation that is important, but the value of that innovation. In health care innovation should generate “value” by (1) improving patients’ quality and/or or length of life and/or…

Postdoctoral Position in The Economics of Life Sciences R&D

27 June 2017

…qualification in economics or health economics, with a special focus on the economics of innovation/industrial organisation. Experience in a pharmaceutical, health care or related industry, or in academia with a…

What is the impact of Uniform Pricing, Indication-Based Pricing (IBP) and alternative commercial arrangements for new pharmaceuticals in the UK NHS?

19 November 2024

…health compared to UP at current approval norms. In the dynamic scenario, authors incorporate the effects of reward level on the production of future innovation (i.e. acknowledging the impact of…

Looking Further Afield – What Can Health Economics Learn from the Environmental Economics Approach to Discounting?

1 February 2024

…majority of relevant interventions apply to a single individual rather than across generations. Despite this, an ethically ambiguous prioritisation of certain groups through the application of a pure rate of…

Graduate School

…Current applications Consideration for the OHE MSc Fellowship is conditional to being admitted to the MSc in Health Economics part-time programmes at the Department of Economics of City St George’s, University of…

Unpacking the Black Box of Payer Policy: A Demand-Side Approach for Equitable Uptake of Cost-Effective Health Innovation

21 February 2020

…a dedicated Innovation Uptake Institute, the global health community can begin to address some of the deep challenges related to misaligned innovation and low uptake of new and cost-effective products—improving…

The Broader Value of Existing Vaccines in the Fight Against COVID-19: Beware of Tunnel Vision

8 October 2020

…at: https://www.ohe.org/publications/meningococcal-vaccines-international-comparison-decisionmaking-processes-frameworks Berdud, M., Towse, A., Jofre-Bonet, M., 2020. The Economics of Innovation in Times of Pandemic: How to Incentivise the Development, Supply, and Continuous Improvement of Innovative Solutions to…